Thrombotic thrombocytopenic purpura: Reducing the risk?

Journal of Clinical Investigation

Volumn 121, Issue 2, 2011, Pages 522-524

  Berndt, Michael C ^a   Andrews, Robert K ^b  

^a DUBLIN CITY UNIVERSITY   (Ireland)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; POLYMER; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIFE; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; RISK REDUCTION; THROMBOCYTE AGGREGATION; THROMBOSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; THROMBUS;

ACETYLCYSTEINE; ADAM PROTEINS; ANIMALS; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; PLATELET AGGREGATION; PURPURA, THROMBOTIC THROMBOCYTOPENIC; THROMBOSIS; VON WILLEBRAND FACTOR;

EID: 79551544276     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI46091     Document Type: Note

References (21)

1. George JN. How I treat patients with thrombotic thrombocytopenic purpura: 2010. Blood. 2010;116(20):4060-4069.
2. Chen J, et al. N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice. J Clin Invest. 2011;121(2):593-603.
3. Lenting PJ, Pegon JN, Groot E, de Groot PG. Regulation of von Willebrand factor-platelet interactions. Thromb Haemostas. 2010;104(3):449-455.
4. Sadler JE. von Willebrand factor assembly and secretion. J Thromb Haemostas. 2010;7 suppl 1:24-27.
5. Yago T, et al. Platelet glycoprotein Iba forms catch bonds with WT VWF but not with type 2B von Willebrand Disease VWF. J Clin Invest. 2008;118(9):3195-3207.
6. Kim J, Zhang CZ, Zhang X, Springer TA. A mechanically stabilized receptor-ligand f lexbond important in the vasculature. Nature. 2010;466(7309):992-995.
7. Fujimura Y, et al. von Willebrand factor. A reduced and alkylated 52/48-kDa fragment beginning at amino acid residue 449 contains the domain interacting with platelet glycoprotein Ib. J Biol Chem. 1986;261(1):381-385.
8. Andrews RK, Gorman JJ, Booth WJ, Corino GL, Castaldi PA, Berndt MC. Cross-linking of a monomeric 39/34-kDa dispase fragment of von Willebrand factor (Leu-480/Val-481-Gly-718) to the N-terminal region of the a-chain of membrane glycoprotein Ib on intact platelets with b is(sulfosuccinimidyl)suberate. Biochemistry. 1989;28(21):8326-8336.
9. Huizinga EG, et al. Structures of glycoprotein Iba and its complex with von Willebrand factor A1 domain. Science. 2002;297(5584):1176-1179.
10. Dumas JJ, et al. Crystal structure of the wild-type von Willebrand factor A1-glycoprotein Iba complex reveals conformation differences with a complex bearing von Willebrand disease mutations. J Biol Chem. 2004;279(22):23327-23334.
11. Shen Y, et al. Leucine-rich repeats 2-4 (Leu60-Glu128) of platelet glycoprotein Iba regulate shear-dependent cell adhesion to von Willebrand factor. J Biol Chem. 2006;281(36):26419-26423. (Pubitemid 44401850)
12. Dong JF, et al. ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions. Blood. 2002;100(12):4033-4039.
13. Zhou Z, Nguyen TC, Guchhait P, Dong JF. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura. Semin Thromb Hemost. 2010;36(1):71-81.
14. Buzza MS, et al. Antihemostatic activity of human granzyme B mediated by cleavage of von Willebrand factor. J Biol Chem. 2008;283(33):22498-22504.
15. Raife TJ, et al. Leukocyte proteases cleave von Willebrand factor at or near the ADAMTS13 cleavage site. Blood. 2009;114(8):1666-1674.
16. Baldauf C, et al. Shear-induced unfolding activates von Willebrand factor A2 domain for proteolysis. J Thromb Haemost. 2009;7(12):2096-2105.
17. George JN. ADAMTS13 alone. Blood. 2010;116(12):2003-2004.
18. Feys HB, et al. Thrombotic thrombocytopenic purpura directly linked with ADAMTS13 inhibition in the baboon (Papio ursinus). Blood. 2010;116(12):2005- 2010.
19. Yeh HC, et al. Disulfide bond reduction of von Willebrand factor by ADAMTS-13. J Thromb Haemost. 2010;8(12):2778-2788.
20. Anfossi G, Russo I, Massucco P, Mattiello L, Cavalot F, Trovati M. N-acetyl-L-cysteine exerts direct antiaggregating effect on human platelets. Eur J Clin Invest. 2001;31(5):452-461. (Pubitemid 32476965)
21. Jepsen S, Hansen AB. The influence of N-acetylcysteine on the measurement of prothrombin time and activated partial thromboplastin time in healthy subjects. Scand J Clin Lab Invest. 1994;54(7):543-547.